Coforge FY25 Annual Earnings Summary

Revenue from top 5 clients declined due to normalization in banking; if macro uncertainty delays program transitions, growth could be slower than expected.

Wage hikes effective July 1 will depress margins by 130-150 bps in Q2, though management expects efficiencies to offset partially.

Merger process may take 9-12 months; any delays or cultural friction could impact expected synergies and margin expansion.

Incremental ESOP cost of ~120bps per quarter in H2 FY25 will pressure reported EBITDA margins.

Some GCC deals have a build-operate-transfer structure, leading to potential revenue cliff after the initial mandate period.

Analyst raised concerns about demand environment during budget season; management acknowledged gradual improvement but risks remain if macro conditions worsen.

Geopolitical uncertainty and cautious airline spending may impact travel vertical growth, though management remains confident.

Sabre's high debt ($4.7B) and recent profit warnings raise concerns; Coforge has taken credit insurance and non-recourse factoring.

Analyst raised concern that GenAI could deflate volumes in testing; management downplayed risk but acknowledged functional testing may be impacted.

Management expects normal furloughs in Q3, which could temper the strong sequential growth trajectory.

While management expects no further past liabilities, integration expenses may persist for a couple of quarters.

Cigniti merger involves ongoing integration costs; CFO noted expenses were $1.9M in Q3 and expected to decline but could persist.